» Articles » PMID: 21893977

Reduction in Serum High Mobility Group Box-1 Level by Polymyxin B-immobilized Fiber Column in Patients with Idiopathic Pulmonary Fibrosis with Acute Exacerbation

Overview
Journal Blood Purif
Specialty Hematology
Date 2011 Sep 7
PMID 21893977
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aim: Recent reports suggest that polymyxin B (PMX)-immobilized fiber may have beneficial effects in idiopathic pulmonary fibrosis (IPF) with acute exacerbation (AE). High mobility group box-1 (HMGB-1) is an important pro-inflammatory mediator that contributes to acute lung inflammation. This study was aimed to investigate whether PMX treatment affects serum HMGB-1 levels and oxygenation in IPF patients with AE.

Materials And Methods: Twenty IPF patients with AE were treated by PMX. PMX treatment was carried out once daily for 2 successive days. Serum HMGB-1 levels were measured before and after PMX treatment. We also monitored arterial oxygen tension (PaO(2))/inspiratory oxygen fraction (FiO(2)) (P/F) ratio. PMX fiber columns were analyzed to examine whether HMGB-1 was absorbed by PMX.

Results: PMX treatment significantly improved both the serum HMGB-1 level and P/F ratio. HMGB-1 was detected in washing medium from the PMX column.

Conclusion: PMX treatment may reduce serum HMGB-1 and improve oxygenation in patients with IPF with AE.

Citing Articles

Polymyxin B-immobilised fibre column treatment for acute exacerbation of idiopathic pulmonary fibrosis patients with mechanical ventilation: a nationwide observational study.

Awano N, Jo T, Izumo T, Inomata M, Ito Y, Morita K J Intensive Care. 2023; 11(1):45.

PMID: 37821999 PMC: 10568810. DOI: 10.1186/s40560-023-00693-0.


Pathological Roles of Pulmonary Cells in Acute Lung Injury: Lessons from Clinical Practice.

Enomoto N Int J Mol Sci. 2022; 23(23).

PMID: 36499351 PMC: 9736972. DOI: 10.3390/ijms232315027.


Efficacy and Safety of Direct Hemoperfusion Using Polymyxin B-Immobilized Polystyrene Column for Patients With COVID-19: Protocol for an Exploratory Study.

Terada-Hirashima J, Izumi S, Katagiri D, Uemura Y, Mikami A, Sugiura W JMIR Res Protoc. 2022; 11(11):e37426.

PMID: 36126219 PMC: 9674082. DOI: 10.2196/37426.


Acute exacerbation of interstitial lung disease in the intensive care unit.

Charokopos A, Moua T, Ryu J, Smischney N World J Crit Care Med. 2022; 11(1):22-32.

PMID: 35433309 PMC: 8788209. DOI: 10.5492/wjccm.v11.i1.22.


Predictive role of circulatory HMGB1 in postoperative acute exacerbation of interstitial lung disease in lung cancer patients.

Yamaguchi K, Nakao S, Iwamoto H, Kagimoto A, Handa Y, Sakamoto S Sci Rep. 2021; 11(1):10105.

PMID: 33980944 PMC: 8115343. DOI: 10.1038/s41598-021-89663-w.